Health services

Tender description

The overall aim of this service is to improve patient access to anticoagulation; including discussions about the most appropriate choice of anticoagulant and then if the choice is warfarin, initiation and monitoring. This service must be close to home, and a more convenient service for patients with increased local capacity to meet the demand for treatment with anticoagulants. The intention is to provide a comprehensive, community based, consultant led service for patients needing anticoagulation. The service must be delivered to all appropriate patients registered with GP practices in NHS City and Hackney CCG and ensure equitable access and quality of service to the entire population group. Service locations will need to be agreed with the CCG using existing assets to good effect and should minimise travel for patients. Please refer to additional information section VI.3 for more details. The overall aim of this service is to improve patient access to anticoagulation; including discussions about the most appropriate choice of anticoagulant and then if the choice is warfarin, initiation and monitoring. This service must be close to home, and a more convenient service for patients with increased local capacity to meet the demand for treatment with anticoagulants. The intention is to provide a comprehensive, community based, consultant led service for patients needing anticoagulation. The service must be delivered to all appropriate patients registered with GP practices in NHS City and Hackney CCG and ensure equitable access and quality of service to the entire population group. Service locations will need to be agreed with the CCG using existing assets to good effect and should minimise travel for patients. Service Thresholds: —The service provider will be expected to deliver services to 1359 patients in the first year, 1413 in the second year and 1470 in the third year —The priority for mobilisation will be to take patients out of secondary care into the community. The service provider will be expected to increase the number of patients having warfarin managed in the community from existing 623, and add in approximately 90 % of the hospital cohort i.e.1285 by the end of Q3 The service provider will be expected to deliver support for self-testing patients up to 20 patients in the first year, 30 in the second year and 40 in the third year —The service provider participates in a nationally recognised scheme for External Quality Assurance (EQA) and EQA is undertaken at all service delivery sites at the frequency specified by the scheme.